<billStatus>
 <version>
  3.0.0
 </version>
 <bill>
  <number>
   2883
  </number>
  <updateDate>
   2023-05-11T15:46:24Z
  </updateDate>
  <updateDateIncludingText>
   2023-05-11T15:46:24Z
  </updateDateIncludingText>
  <originChamber>
   House
  </originChamber>
  <type>
   HR
  </type>
  <introducedDate>
   2021-04-28
  </introducedDate>
  <congress>
   117
  </congress>
  <constitutionalAuthorityStatementText>
   &lt;pre&gt;[Congressional Record Volume 167, Number 73 (Wednesday, April 28, 2021)][House]From the Congressional Record Online through the Government Publishing Office [&lt;a href="https://www.gpo.gov"&gt;www.gpo.gov&lt;/a&gt;]By Mr. JEFFRIES:H.R. 2883.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8, Clause 18, to make all laws whichshall be necessary and proper for carrying into Execution theforegoing Powers, and all other Powers vested by thisConstitution in the Government of the United States, or inany Department or Officer thereof.[Page H2128]&lt;/pre&gt;
  </constitutionalAuthorityStatementText>
  <committees>
   <item>
    <systemCode>
     hsju00
    </systemCode>
    <name>
     Judiciary Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <activities>
     <item>
      <name>
       Markup by
      </name>
      <date>
       2021-09-29T21:19:48Z
      </date>
     </item>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-04-28T22:06:00Z
      </date>
     </item>
    </activities>
   </item>
  </committees>
  <relatedBills>
   <item>
    <title>
     Stop STALLING Act
    </title>
    <congress>
     117
    </congress>
    <number>
     1425
    </number>
    <type>
     S
    </type>
    <latestAction>
     <actionDate>
      2021-12-08
     </actionDate>
     <text>
      Placed on Senate Legislative Calendar under General Orders. Calendar No. 179.
     </text>
    </latestAction>
    <relationshipDetails>
     <item>
      <type>
       Related bill
      </type>
      <identifiedBy>
       CRS
      </identifiedBy>
     </item>
    </relationshipDetails>
   </item>
  </relatedBills>
  <actions>
   <item>
    <actionDate>
     2021-09-29
    </actionDate>
    <committees>
     <item>
      <systemCode>
       hsju00
      </systemCode>
      <name>
       Judiciary Committee
      </name>
     </item>
    </committees>
    <sourceSystem>
     <code>
      1
     </code>
     <name>
      House committee actions
     </name>
    </sourceSystem>
    <text>
     Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 31 - 9.
    </text>
    <type>
     Committee
    </type>
   </item>
   <item>
    <actionDate>
     2021-09-29
    </actionDate>
    <committees>
     <item>
      <systemCode>
       hsju00
      </systemCode>
      <name>
       Judiciary Committee
      </name>
     </item>
    </committees>
    <sourceSystem>
     <code>
      1
     </code>
     <name>
      House committee actions
     </name>
    </sourceSystem>
    <text>
     Committee Consideration and Mark-up Session Held.
    </text>
    <type>
     Committee
    </type>
   </item>
   <item>
    <actionDate>
     2021-04-28
    </actionDate>
    <text>
     Referred to the House Committee on the Judiciary.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hsju00
      </systemCode>
      <name>
       Judiciary Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-04-28
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     Intro-H
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
   <item>
    <actionDate>
     2021-04-28
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     1000
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
  </actions>
  <sponsors>
   <item>
    <bioguideId>
     J000294
    </bioguideId>
    <fullName>
     Rep. Jeffries, Hakeem S. [D-NY-8]
    </fullName>
    <firstName>
     Hakeem
    </firstName>
    <lastName>
     Jeffries
    </lastName>
    <party>
     D
    </party>
    <state>
     NY
    </state>
    <middleName>
     S.
    </middleName>
    <district>
     8
    </district>
    <isByRequest>
     N
    </isByRequest>
   </item>
  </sponsors>
  <cosponsors>
   <item>
    <bioguideId>
     B001297
    </bioguideId>
    <fullName>
     Rep. Buck, Ken [R-CO-4]
    </fullName>
    <firstName>
     Ken
    </firstName>
    <lastName>
     Buck
    </lastName>
    <party>
     R
    </party>
    <state>
     CO
    </state>
    <district>
     4
    </district>
    <sponsorshipDate>
     2021-04-28
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     N000002
    </bioguideId>
    <fullName>
     Rep. Nadler, Jerrold [D-NY-10]
    </fullName>
    <firstName>
     JERROLD
    </firstName>
    <lastName>
     NADLER
    </lastName>
    <party>
     D
    </party>
    <state>
     NY
    </state>
    <district>
     10
    </district>
    <sponsorshipDate>
     2021-04-28
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     C001084
    </bioguideId>
    <fullName>
     Rep. Cicilline, David N. [D-RI-1]
    </fullName>
    <firstName>
     David
    </firstName>
    <lastName>
     Cicilline
    </lastName>
    <party>
     D
    </party>
    <state>
     RI
    </state>
    <middleName>
     N.
    </middleName>
    <district>
     1
    </district>
    <sponsorshipDate>
     2021-04-28
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     M000087
    </bioguideId>
    <fullName>
     Rep. Maloney, Carolyn B. [D-NY-12]
    </fullName>
    <firstName>
     CAROLYN
    </firstName>
    <lastName>
     MALONEY
    </lastName>
    <party>
     D
    </party>
    <state>
     NY
    </state>
    <middleName>
     B.
    </middleName>
    <district>
     12
    </district>
    <sponsorshipDate>
     2021-04-28
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     O000086
    </bioguideId>
    <fullName>
     Rep. Owens, Burgess [R-UT-4]
    </fullName>
    <firstName>
     Burgess
    </firstName>
    <lastName>
     Owens
    </lastName>
    <party>
     R
    </party>
    <state>
     UT
    </state>
    <district>
     4
    </district>
    <sponsorshipDate>
     2021-09-24
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     J000032
    </bioguideId>
    <fullName>
     Rep. Jackson Lee, Sheila [D-TX-18]
    </fullName>
    <firstName>
     SHEILA
    </firstName>
    <lastName>
     JACKSON LEE
    </lastName>
    <party>
     D
    </party>
    <state>
     TX
    </state>
    <district>
     18
    </district>
    <sponsorshipDate>
     2021-09-28
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     D000627
    </bioguideId>
    <fullName>
     Rep. Demings, Val Butler [D-FL-10]
    </fullName>
    <firstName>
     Val
    </firstName>
    <lastName>
     Demings
    </lastName>
    <party>
     D
    </party>
    <state>
     FL
    </state>
    <middleName>
     Butler
    </middleName>
    <district>
     10
    </district>
    <sponsorshipDate>
     2021-09-28
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     B001305
    </bioguideId>
    <fullName>
     Rep. Budd, Ted [R-NC-13]
    </fullName>
    <firstName>
     Ted
    </firstName>
    <lastName>
     Budd
    </lastName>
    <party>
     R
    </party>
    <state>
     NC
    </state>
    <district>
     13
    </district>
    <sponsorshipDate>
     2022-08-12
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
  </cosponsors>
  <cboCostEstimates>
   <item>
    <pubDate>
     2022-07-22T17:23:00Z
    </pubDate>
    <title>
     Estimated Budgetary Effects of H.R. 2883, the Stop Stalling Access to Affordable Medications Act
    </title>
    <url>
     https://www.cbo.gov/publication/58328
    </url>
    <description>
     As ordered reported by the House Committee on the Judiciary on September 29, 2021
    </description>
   </item>
  </cboCostEstimates>
  <policyArea>
   <name>
    Health
   </name>
  </policyArea>
  <subjects>
   <legislativeSubjects>
    <item>
     <name>
      Administrative remedies
     </name>
    </item>
    <item>
     <name>
      Business ethics
     </name>
    </item>
    <item>
     <name>
      Civil actions and liability
     </name>
    </item>
    <item>
     <name>
      Competition and antitrust
     </name>
    </item>
    <item>
     <name>
      Department of Health and Human Services
     </name>
    </item>
    <item>
     <name>
      Drug safety, medical device, and laboratory regulation
     </name>
    </item>
    <item>
     <name>
      Food and Drug Administration (FDA)
     </name>
    </item>
    <item>
     <name>
      Licensing and registrations
     </name>
    </item>
    <item>
     <name>
      Prescription drugs
     </name>
    </item>
    <item>
     <name>
      Public participation and lobbying
     </name>
    </item>
   </legislativeSubjects>
   <policyArea>
    <name>
     Health
    </name>
   </policyArea>
  </subjects>
  <summaries>
   <summary>
    <versionCode>
     00
    </versionCode>
    <actionDate>
     2021-04-28
    </actionDate>
    <actionDesc>
     Introduced in House
    </actionDesc>
    <updateDate>
     2021-09-14T13:45:23Z
    </updateDate>
    <text>
     &lt;p&gt;&lt;b&gt;Stop Stalling Access to Affordable Medications &lt;/b&gt;&lt;/p&gt; &lt;p&gt;This bill makes it an unfair method of competition to submit an objectively baseless petition to the Food and Drug Administration (FDA) in an attempt to interfere with a competitor's application for market approval of a drug.&lt;/p&gt; &lt;p&gt;The bill authorizes the Federal Trade Commission to sue an individual or entity that submits such a petition to the FDA. A party found liable in such a lawsuit shall be subject to civil penalties, such as a fine of up to $50,000 for each day that the FDA spent reviewing the baseless petition.&lt;/p&gt;
    </text>
   </summary>
  </summaries>
  <title>
   Stop Stalling Access to Affordable Medications
  </title>
  <titles>
   <item>
    <titleType>
     Display Title
    </titleType>
    <title>
     Stop Stalling Access to Affordable Medications
    </title>
   </item>
   <item>
    <titleType>
     Official Title as Introduced
    </titleType>
    <title>
     To enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition and facilitate the efficient review of petitions filed in good faith to raise legitimate public heath concerns, and for other purposes.
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
   <item>
    <titleType>
     Short Title(s) as Introduced
    </titleType>
    <title>
     Stop Stalling Access to Affordable Medications
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
  </titles>
  <textVersions>
   <item>
    <type>
     Introduced in House
    </type>
    <date>
     2021-04-28T04:00:00Z
    </date>
    <formats>
     <item>
      <url>
       https://www.govinfo.gov/content/pkg/BILLS-117hr2883ih/xml/BILLS-117hr2883ih.xml
      </url>
     </item>
    </formats>
   </item>
  </textVersions>
  <latestAction>
   <actionDate>
    2021-09-29
   </actionDate>
   <text>
    Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 31 - 9.
   </text>
  </latestAction>
 </bill>
 <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:format>
   text/xml
  </dc:format>
  <dc:language>
   EN
  </dc:language>
  <dc:rights>
   Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
  </dc:rights>
  <dc:contributor>
   Congressional Research Service, Library of Congress
  </dc:contributor>
  <dc:description>
   This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
  </dc:description>
 </dublinCore>
</billStatus>

2021-09-29
Judiciary Committee
hsju00
1
House committee actions
Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 31 - 9.
Committee
2021-09-29
Judiciary Committee
hsju00
1
House committee actions
Committee Consideration and Mark-up Session Held.
Committee
H11100
2021-04-28
Judiciary Committee
hsju00
2
House floor actions
Referred to the House Committee on the Judiciary.
IntroReferral
Intro-H
2021-04-28
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-04-28
9
Library of Congress
Introduced in House
IntroReferral
As ordered reported by the House Committee on the Judiciary on September 29, 2021
2022-07-22T17:23:00Z
Estimated Budgetary Effects of H.R. 2883, the Stop Stalling Access to Affordable Medications Act
https://www.cbo.gov/publication/58328
2021-09-29T21:19:48Z
Markup by
2021-04-28T22:06:00Z
Referred to
House
Judiciary Committee
hsju00
Standing
B001297
4
Ken
Rep. Buck, Ken [R-CO-4]
Buck
R
2021-04-28
CO
N000002
10
JERROLD
Rep. Nadler, Jerrold [D-NY-10]
NADLER
D
2021-04-28
NY
C001084
1
David
Rep. Cicilline, David N. [D-RI-1]
Cicilline
N.
D
2021-04-28
RI
M000087
12
CAROLYN
Rep. Maloney, Carolyn B. [D-NY-12]
MALONEY
B.
D
2021-04-28
NY
O000086
4
Burgess
Rep. Owens, Burgess [R-UT-4]
Owens
R
2021-09-24
UT
J000032
18
SHEILA
Rep. Jackson Lee, Sheila [D-TX-18]
JACKSON LEE
D
2021-09-28
TX
D000627
10
Val
Rep. Demings, Val Butler [D-FL-10]
Demings
Butler
D
2021-09-28
FL
B001305
13
Ted
Rep. Budd, Ted [R-NC-13]
Budd
R
2022-08-12
NC
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
2021-04-28
2021-09-29
Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 31 - 9.
House
Health
2021-12-08
Placed on Senate Legislative Calendar under General Orders. Calendar No. 179.
CRS
Related bill
Stop STALLING Act
S
J000294
8
Hakeem
Rep. Jeffries, Hakeem S. [D-NY-8]
N
Jeffries
S.
D
NY
Administrative remedies Business ethics Civil actions and liability Competition and antitrust Department of Health and Human Services Drug safety, medical device, and laboratory regulation Food and Drug Administration (FDA) Licensing and registrations Prescription drugs Public participation and lobbying
2021-04-28
Introduced in House
 <p><b>Stop Stalling Access to Affordable Medications </b></p> <p>This bill makes it an unfair method of competition to submit an objectively baseless petition to the Food and Drug Administration (FDA) in an attempt to interfere with a competitor's application for market approval of a drug.</p> <p>The bill authorizes the Federal Trade Commission to sue an individual or entity that submits such a petition to the FDA. A party found liable in such a lawsuit shall be subject to civil penalties, such as a fine of up to $50,000 for each day that the FDA spent reviewing the baseless petition.</p>
2021-09-14T13:45:23Z
00
2021-04-28T04:00:00Z
Introduced in House
https://www.govinfo.gov/content/pkg/BILLS-117hr2883ih/xml/BILLS-117hr2883ih.xml
Stop Stalling Access to Affordable Medications
Stop Stalling Access to Affordable Medications
Display Title
IH
Introduced in House
To enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition and facilitate the efficient review of petitions filed in good faith to raise legitimate public heath concerns, and for other purposes.
Official Title as Introduced
IH
Introduced in House
Stop Stalling Access to Affordable Medications
Short Title(s) as Introduced
HR
2023-05-11T15:46:24Z
2023-05-11T15:46:24Z
3.0.0
2021-12-08
Placed on Senate Legislative Calendar under General Orders. Calendar No. 179.
CRS
Related bill
Stop STALLING Act
S
2021-09-29
Judiciary Committee
hsju00
1
House committee actions
Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 31 - 9.
Committee
2021-09-29
Judiciary Committee
hsju00
1
House committee actions
Committee Consideration and Mark-up Session Held.
Committee
H11100
2021-04-28
Judiciary Committee
hsju00
2
House floor actions
Referred to the House Committee on the Judiciary.
IntroReferral
Intro-H
2021-04-28
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-04-28
9
Library of Congress
Introduced in House
IntroReferral
J000294
8
Hakeem
Rep. Jeffries, Hakeem S. [D-NY-8]
N
Jeffries
S.
D
NY
B001297
4
Ken
Rep. Buck, Ken [R-CO-4]
Buck
R
2021-04-28
CO
N000002
10
JERROLD
Rep. Nadler, Jerrold [D-NY-10]
NADLER
D
2021-04-28
NY
C001084
1
David
Rep. Cicilline, David N. [D-RI-1]
Cicilline
N.
D
2021-04-28
RI
M000087
12
CAROLYN
Rep. Maloney, Carolyn B. [D-NY-12]
MALONEY
B.
D
2021-04-28
NY
O000086
4
Burgess
Rep. Owens, Burgess [R-UT-4]
Owens
R
2021-09-24
UT
J000032
18
SHEILA
Rep. Jackson Lee, Sheila [D-TX-18]
JACKSON LEE
D
2021-09-28
TX
D000627
10
Val
Rep. Demings, Val Butler [D-FL-10]
Demings
Butler
D
2021-09-28
FL
B001305
13
Ted
Rep. Budd, Ted [R-NC-13]
Budd
R
2022-08-12
NC
Administrative remedies Business ethics Civil actions and liability Competition and antitrust Department of Health and Human Services Drug safety, medical device, and laboratory regulation Food and Drug Administration (FDA) Licensing and registrations Prescription drugs Public participation and lobbying
2021-04-28
Introduced in House
 <p><b>Stop Stalling Access to Affordable Medications </b></p> <p>This bill makes it an unfair method of competition to submit an objectively baseless petition to the Food and Drug Administration (FDA) in an attempt to interfere with a competitor's application for market approval of a drug.</p> <p>The bill authorizes the Federal Trade Commission to sue an individual or entity that submits such a petition to the FDA. A party found liable in such a lawsuit shall be subject to civil penalties, such as a fine of up to $50,000 for each day that the FDA spent reviewing the baseless petition.</p>
2021-09-14T13:45:23Z
00
Stop Stalling Access to Affordable Medications
Stop Stalling Access to Affordable Medications
Display Title
IH
Introduced in House
To enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition and facilitate the efficient review of petitions filed in good faith to raise legitimate public heath concerns, and for other purposes.
Official Title as Introduced
IH
Introduced in House
Stop Stalling Access to Affordable Medications
Short Title(s) as Introduced
2021-09-29
Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 31 - 9.